C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2626069
The present invention, in general, relates to use of nm23H1-B gene for diagnosing cancer susceptibility and metastatic progression in colon/colorectal cancer. In particular, the present invention relates to identifying the alteration in the expression of nm23H1-B gene on treatment with chemotherapeutic agents for diagnosing cancer susceptibility and metastatic progression in colon/colorectal cancer.
La présente invention concerne, d'une façon générale, l'utilisation du gène nm23H1-B pour diagnostiquer la prédisposition au cancer et la progression métastatique dans le cancer du côlon/colorectal. En particulier, la présente invention concerne l'identification de l'altération de l'expression du gène nm23H1-B lors du traitement avec des agents de chimiothérapie pour diagnostiquer la prédisposition au cancer et la progression métastatique dans le cancer du côlon/colorectal.
Burman Anand C.
Chandra Harish
Maithal Kapil
Mukherjee Rama
Borden Ladner Gervais Llp
Dabur Pharma Limited
LandOfFree
A diagnostic marker and therapeutic target for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A diagnostic marker and therapeutic target for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A diagnostic marker and therapeutic target for cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2009094